Tamoxifen in the Treatment of Recurrent Ovarian Carcinoma
- 1 July 1997
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 7 (4) , 256-261
- https://doi.org/10.1046/j.1525-1438.1997.00463.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Epithelial ovarian carcinomaThe Lancet, 1997
- Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary ReportGynecologic Oncology, 1996
- Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell linesBritish Journal of Cancer, 1994
- Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patientsCancer, 1991
- Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleBritish Journal of Cancer, 1988
- Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinomaGynecologic Oncology, 1987
- Tamoxifen therapy in recurrent epithelial ovarian carcinomaGynecologic Oncology, 1987
- A phase II study of tamoxifen in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- 216 Treatment of advanced ovarian carcinoma with tamoxifen. a phase II trialJournal of Steroid Biochemistry, 1983
- Advanced ovarian carcinoma: Response to antiestrogen therapyCancer, 1981